TACSTD2 and breast carcinoma: Trophoblastic cell surface antigen-2 (Trop-2, also known as EGP-1, encoded by TACSTD2) is a transmembrane glycoprotein overexpressed in 83% of breast cancer cases [267] and 85% of TNBCs [268].